Ge Healthcare Company Profile

✉ Email this page to a colleague

GE HEALTHCARE has fifty approved drugs.

There are four US patents protecting GE HEALTHCARE drugs.

There are eighty patent family members on GE HEALTHCARE drugs in twenty-six countries and one hundred and thirty-seven supplementary protection certificates in eighteen countries.

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ge Healthcare	XENON XE 133	xenon xe-133	INJECTABLE;INJECTION	017256-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Ge Healthcare	SODIUM IODIDE I 123	sodium iodide i-123	CAPSULE;ORAL	017630-003	Jan 8, 1993		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Ge Healthcare	VISIPAQUE 270	iodixanol	INJECTABLE;INJECTION	020351-001	Mar 22, 1996	AP	RX	Yes	Yes		⤷ Try a Trial				⤷ Try a Trial
Ge Healthcare	HYPAQUE	diatrizoate sodium	FOR SOLUTION;ORAL, RECTAL	011386-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Ge Healthcare	HYPAQUE	diatrizoate sodium	INJECTABLE;INJECTION	009561-003	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Ge Healthcare	VISIPAQUE 270	iodixanol	INJECTABLE;INJECTION	020351-001	Mar 22, 1996	4,396,597	⤷ Try a Trial
Ge Healthcare	OMNIPAQUE 180	iohexol	SOLUTION;INJECTION, ORAL, RECTAL	018956-001	Dec 26, 1985	4,396,597	⤷ Try a Trial
Ge Healthcare	OMNIPAQUE 350	iohexol	SOLUTION;INJECTION, ORAL	018956-004	Dec 26, 1985	4,250,113	⤷ Try a Trial
Ge Healthcare	VISIPAQUE 320	iodixanol	INJECTABLE;INJECTION	020351-002	Mar 22, 1996	5,349,085	⤷ Try a Trial
Ge Healthcare	ISOPAQUE 440	calcium metrizoate; meglumine metrizoate; metrizoate magnesium; metrizoate sodium	INJECTABLE;INJECTION	016847-001	Approved Prior to Jan 1, 1982	3,476,802	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0933372	13/2008	Austria	⤷ Try a Trial	PRODUCT NAME: FOSAMPRENAVIR ALS FOSAMPRENAVIR-CALCIUM; REGISTRATION NO/DATE: EU/1/04/282/001 - EU/1/04/282/002 (MITTEILUNG VOM 14.07.2004) 20040713
1853250	132014902271575	Italy	⤷ Try a Trial	PRODUCT NAME: PACLITAXEL LEGATO ALL'ALBUMINA FORMULATO IN NANOPARTICELLE(ABRAXANE); AUTHORISATION NUMBER(S) AND DATE(S): EU/01/07/428, 20131220
0961612	09C0050	France	⤷ Try a Trial	PRODUCT NAME: PACLITAXEL ALBUMINE; REGISTRATION NO/DATE: EU/1/07/428/001 20080111
0579826	02C0041	France	⤷ Try a Trial	PRODUCT NAME: ERTAPENEM SODIUM; REGISTRATION NO/DATE: EU/1/02/216/001 20020418
0961612	C00961612/01	Switzerland	⤷ Try a Trial	PRODUCT NAME: PACLITAXELUM-ALBUMINUM; REGISTRATION NO/DATE: SWISSMEDIC 63182 26.08.2014
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.